The global Lab automation in drug discovery market is expected to register a CAGR of 6.32 %, during the forecast period (2018 - 2023). An automated system coupled with modern pharma has a huge impact on the human life. Automated systems, such as high throughput screening operations, compound repositories, and chemistry labs have become prevalent in core labs and becoming popular in academic environments. The extent of automation required dependent on the nature of the task to be performed, the need for processing and the amount of human intervention. Automation tools were able to process concurrent requests in real time, and were responsible for a marked improvement in productivity and throughput. They have greatly helped clinical and pre-clinical studies by developing, optimizing and streamlining the workflow; researchers are able to achieve greater efficiency within a shorter time span. North America has been the biggest contributor to growth in this market due to high levels of health awareness, presence of major R&D firms and emphasis on optimizing workflows by minimizing human intervention.
Companies are focused on generating quantitative data for drug discovery, diagnostics, and research teams. This discipline has been greatly aided by scientific and technological advances that have led to greater reliability and throughput. Automation tools need to be simple, yet intuitive to use; device miniaturization has been a gradual trend in this regard. The new classes of devices are rugged, fault tolerant, reliable and are able to connect with other systems to report data, and interact with management systems for generating sample trends. Drug discovery agencies are making use of robotic handlers and automated software to reduce the risk of error and to streamline their workflows for achieving greater throughput.
Automated liquid handlers are used in lab automation as it reduces time for processing, owing less sample contamination and increasing accuracy. There is a strong demand for automated liquid handling with sensor-integrated systems for dealing with small volumes. Liquid handling plays a pivotal role in applications like genomic and proteomic research as samples are being dispensed for smoothening the workflow.
In the modern era, the need of automated liquid handling has proved to be a boon for various applications, which increase efficiency. Companies like Hudson Robotics and Aurora have been continuously making developments in automated liquid handlers for delivering newer and more reliable equipment for laboratories, which reduce errors.
North America is the market leader in this market followed by Europe. Asia-Pacific and Latin America are emerging as there has been a considerable increase in outsourcing pharmaceutical manufacturing to these regions due to the availability of cheaper labor and resources. Various aspects, such as growing reproducibility and accuracy, miniaturization in the process, progressing drug discovery, clinical diagnostics, and large gap in workforce demand and supply, have driven the growth of the market. Strict regulations laid down by the United States government and the FDA, along with the growing demand in the diagnostic market, and the increasing usage of the discovery and research labs owing to the rising presence of various diseases, such as cardiovascular diseases and neurological diseases in the region, has fuelled the growth of the market. United States dominates the North American market and is the major revenue contributor in the region.
Major Players: Thermo Fisher Scientific, Beckman Coulter, Hudson Robotics, Becton Dickinson, Synchron Lab Automation, Agilent Technologies, Siemens Healthcare, Tecan Group Ltd, Perkinelmer, Bio-Rad, Roche Holding AG, Eppendorf AG, Shimadzu Corp. and Aurora Biomed, amongst others.
Looking to Customize Report?